FATE

NASDAQ · Equity

Fate Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.840000
Fair value
2.600864
Expectation
Negative 42.68%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.84
12-Week Change
142.74%
Trend Signal
Active
Expectation
Negative 42.68%
Signal Weeks
9 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
83.08
Market Dynamics
1.79

Over the latest 12 completed weeks ending 2026-05-29, FATE rose 142.74%, moving from 1.17 to 2.84. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 83.08 and has improved across the 12-week window. Market Dynamics is 1.79 on the latest week. Expectation is negative at 42.68%.